Long-term survival of biological therapy in psoriatic arthritis: 18-year analysis of a cohort in a tertiary hospital-Reference-Cited by-同舟云学术

Long-term survival of biological therapy in psoriatic arthritis: 18-year analysis of a cohort in a tertiary hospital

Published:2021-06-30 Issue: Volume: Page:
ISSN:0172-8172
Container-title:Rheumatology International
language:en
Short-container-title:Rheumatol Int

Author:

Mateo Soria Lourdes^ORCID,Prior-Español Águeda,Grigorov Mihail Mihaylov,Holgado-Pérez Susana,Aparicio-Espinar María,Martinez-Morillo Melania,Olivé-Marqués Alejandro

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s00296-021-04928-x.pdf

Reference19 articles.

1. Glintborg B, Østergaard M, Dreyer L et al (2011) Treatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti-tumor necrosis factor α therapy: results from the nationwide Danish DANBIO registry. Arthritis Rheum 63:382–390. https://doi.org/10.1002/art.30117

2. Stober C, Ye W, Guruparan T et al (2018) Prevalence and predictors of tumour necrosis factor inhibitor persistence in psoriatic arthritis. Rheumatology 57:158–163. https://doi.org/10.1093/rheumatology/kex387

3. Carmona L, Gómez-Reino JJ (2006) Survival of TNF antagonists in spondyloarthritis is better than in rheumatoid arthritis. Data from the Spanish registry BIOBADASER. Arthritis Res Ther 8:72. https://doi.org/10.1186/ar1941

4. Cañete JD, Naranjo A, Calvo J et al (2020) Biological treatment patterns in patients with inflammatory joint diseases. Retrospective study with 4 years follow-up. Reumatol Clínica Engl Ed 16:447–454. https://doi.org/10.1016/j.reumae.2018.11.016

5. Saad AA, Ashcroft DM, Watson KD et al (2009) Persistence with anti-tumor necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics Register. Arthritis Res Ther 11:R52. https://doi.org/10.1186/ar2670

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex- and gender-related differences in psoriatic arthritis;Nature Reviews Rheumatology;2022-08-04

2. Long‐Term Efficacy and Safety of Guselkumab, a Monoclonal Antibody Specific to the p19 Subunit of Interleukin‐23, Through Two Years: Results From a Phase III , Randomized, Double‐Blind , Placebo‐Controlled Study Conducted in Biologic‐Naive Patients With Active Psoriatic Arthritis;Arthritis & Rheumatology;2022-02-07